Related Experiment Video
Updated: Jun 28, 2025
08:02
Phospholipid Mediator Induced Transformation in Three-Dimensional Cultures
Published on: July 27, 2022
2.4K
PTPLAD1 Regulates PHB-Raf Interaction to Orchestrate Epithelial-Mesenchymal and Mitofusion-Fission Transitions in
Zi-Jia Huang1, Yang-Jia Li1, Jie Yang1
1MOE Key Laboratory of Tumor Molecular Biology and State Key Laboratory of Bioactive Molecules and Druggability Assessment, College of Life Science and Technology, Jinan University, Guangzhou 510632, China.
International Journal of Biological Sciences
|April 15, 2024
Summary
Protein tyrosine phosphatase-like A domain containing 1 (PTPLAD1) suppresses colorectal cancer (CRC) metastasis by inhibiting epithelial-to-mesenchymal transition (EMT) and mitochondrial fission. PTPLAD1 down-regulation is linked to poor CRC patient survival.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Colorectal cancer (CRC) is a leading cause of cancer mortality globally.
- Metastasis, driven by persistent cancer signaling, significantly worsens CRC prognosis.
- Protein tyrosine phosphatase-like A domain containing 1 (PTPLAD1) is identified as a potential tumor suppressor.
Purpose of the Study:
- To investigate the role of PTPLAD1 in colorectal cancer metastasis.
- To elucidate the molecular mechanisms by which PTPLAD1 affects cancer progression.
- To explore PTPLAD1 as a potential therapeutic target for metastatic CRC.
Main Methods:
- Analysis of PTPLAD1 expression in metastatic CRC cells and patient survival data.
- In vivo and in vitro studies to assess the effect of PTPLAD1 overexpression on CRC metastasis.
- Investigation of PTPLAD1's interaction with PHB and its impact on Raf/ERK signaling and mitochondrial dynamics.
Main Results:
- PTPLAD1 is down-regulated in highly metastatic CRC cells and associated with poor patient survival.
- PTPLAD1 overexpression inhibits CRC metastasis by suppressing epithelial-to-mesenchymal transition (EMT) and mitochondrial fission.
- PTPLAD1 dephosphorylates PHB-Y259, disrupting PHB-Raf interaction and inactivating Raf/ERK signaling.
Conclusions:
- PTPLAD1 acts as a novel suppressor of CRC metastasis.
- The Raf/ERK signaling pathway mediates both EMT and mitochondrial fission in metastatic CRC.
- PTPLAD1 represents a potential therapeutic target for improving CRC treatment strategies.
Related Concept Videos
01:22Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.2K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.2K
01:22PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
01:19Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
02:38The Ras Gene
6.2K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.2K